Clinical trial
FearLess in Cognitively Intact Patients With Glioma
NCT05604365 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FearLess in Cognitively Intact Patients With Glioma
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 7, 2022
- Completion date
- November 14, 2023
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fear of cancer, glioma